Mar 25, 2013
Multinationals Threatening Domestic Growth of India’s Generics Firms, Says GlobalData...
Mar 25, 2013
Psoriasis has a complex collection of risk factors, such as genetics, lifestyle choices, and exposure to certain environmental...
Mar 20, 2013
Global nuclear energy generation will climb by almost 30% by the end of the decade, thanks in part to an influx of new nations developing nuclear programs, says research and consulting firm GlobalData.
Mar 19, 2013
Joint surgery looks to embrace more and more technologically advanced endeavours, in an effort to give arthritis sufferers their freedom of movement back, states a new report by GlobalData.
Mar 19, 2013
Dry eye syndrome is one of the most common ophthalmological disorders, causing chronic discomfort in up to 100 million people worldwide, and the disease burden is forecast to increase as the average life expectancy rises, says a new report by research...
Mar 18, 2013
National healthcare practices affect the diagnosis rate and survival rate of any disease, and CF patients can sometimes experience substantially different lives depending on the country they are born and treated in, states a new report by research and...
Mar 14, 2013
Total Ankle Replacements (TARs) are gradually becoming a mainstream solution to painful and debilitating trauma within the medical devices industry, states a new report by research and consulting firm GlobalData.
Mar 13, 2013
Cultural and social modesty is leaving women uncomfortable discussing Postmenopausal Vaginal Atrophy (PVA) – a condition which goes underdiagnosed worldwide, states a new report by research and consulting firm GlobalData.
Mar 12, 2013
Respiratory syncytial virus (RSV) infections account for a significant portion of healthcare resources consumed across the US, as the health of vulnerable infants is seriously threatened by the common winter ailment, states a new report by GlobalData.
Mar 12, 2013
A major paradigm shift in late and mid-stage product development from anti-resorptive therapies to anabolic drugs will prove the key driver in the global osteoporosis market, states research and consulting firm GlobalData.